InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Monday, 04/01/2019 3:20:38 PM

Monday, April 01, 2019 3:20:38 PM

Post# of 20
News: $ANGO AngioDynamics Receives FDA Approval to Initiate NanoKnife® DIRECT Clinical Study for the Treatment of Stage III Pancreatic Cancer

AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and oncology, today announced that the United States Food and Drug Administration (FDA) approved the Company’s investigational devic...

Find out more https://marketwirenews.com/news-releases/angiodynamics-receives-fda-approval-to-initiate-nanoknife-xae-direct-clinical-study-for-the-treatment-of-stage-iii-pancreatic-cancer-7921838.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ANGO News